Your browser doesn't support javascript.
loading
Beta-1-Selective Beta-Blockers and Cognitive Functions in Patients With Coronary Artery Disease: A Cross-Sectional Study.
Burkauskas, Julius; Noreikaite, Aurelija; Bunevicius, Adomas; Brozaitiene, Julija; Neverauskas, Julius; Mickuviene, Narseta; Bunevicius, Robertas.
Affiliation
  • Burkauskas J; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
  • Noreikaite A; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
  • Bunevicius A; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
  • Brozaitiene J; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
  • Neverauskas J; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
  • Mickuviene N; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
  • Bunevicius R; From the Behavioral Medicine Institute (JBu, JBr, JN, NM, AB, RB), Lithuanian University of Health Sciences, Palanga, Lithuania; the Institute of Physiology and Pharmacology (AN), Lithuanian University of Health Sciences, Kaunas, Lithuania; and the Laboratory of Clinical Research, Institute of Neuro
J Neuropsychiatry Clin Neurosci ; 28(2): 143-6, 2016.
Article in En | MEDLINE | ID: mdl-26715033
The association between current beta-1-selective beta-blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta-1-selective beta-blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Cognition / Adrenergic beta-Antagonists / Learning Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neuropsychiatry Clin Neurosci Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Cognition / Adrenergic beta-Antagonists / Learning Type of study: Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neuropsychiatry Clin Neurosci Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2016 Type: Article